Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Preliminary results reported for Biojector 2000-delivered malaria vaccine

Dec. 29, 1999

Japanese patent covers BioSante's novel vaccine adjuvant/drug delivery system

Dec. 28, 1999

CV Technologies' ginseng extract enters phase II for respiratory infection prophylaxis

Dec. 27, 1999

Aviron's FluMist protects against influenza infection

Dec. 27, 1999

Oxo Chemie reports promising data for immune therapeutic

Dec. 22, 1999

Synthetic immunogens useful for preparation of HPV preventive vaccine

Dec. 20, 1999

La Jolla presents positive results from animal studies of xenotransplantation drug

Dec. 17, 1999

Vasogen to commence clinical trials of VAS-981 for prevention of GVHD

Dec. 16, 1999

New chikungunya virus vaccine safe and highly immunogenic in humans

Dec. 13, 1999

Recombinant HEV vaccine: safety and immunogenicity in monkeys and humans

Dec. 13, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...